MoneyWorks4Me

Ambalal Sarabhai Enterprises’ arm clears USFDA inspection for GMP compliance

17 Feb 2020 Evaluate

Ambalal Sarabhai Enterprises’ wholly owned subsidiary -- Synbiotics has successfully cleared the United States Food and Drug Administration (USFDA) inspection consecutively 5th time for GMP compliance without any regulatory actions.

Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..